| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |